The Patent Finder

Seldar Pharma Inc.

Also on record
Records under this name other than patents Seldar Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Seldar Pharma Inc.

PatentTitleStatus Expires Confidence
US 9,526,719Tetrahydroisoquinolin-1-one derivative or salt thereof
Lapsed on the fee record
Ended Dec 27, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 27, 2024From the USPTO record
US 8,101,580Therapeutic Agent for Irritable Bowel Syndrome
Lapsed on the fee record
Ended Jan 24, 2024 · High confidence
Lapsed on the fee recordEnded Jan 24, 2024High confidence
US 10,532,048Tetrahydroisoquinolin-1-one derivative or salt thereof
Lapsed on the fee record
Ended Jan 14, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jan 14, 2024From the USPTO record
US 9,150,541Tetrahydroisoquinolin-1-one derivative or salt thereof
Lapsed on the fee record
Ended Oct 6, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 6, 2023From the USPTO record
US 10,016,410Tetrahydroisoquinolin-1-one derivative or salt thereof
Lapsed on the fee record
Ended Jul 10, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jul 10, 2022From the USPTO record
US 8,486,970TETRAHYDROISOQUINOLIN-1-ONE Derivative or Salt Thereof
Lapsed on the fee record
Ended Jul 16, 2021 · High confidence
Lapsed on the fee recordEnded Jul 16, 2021High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited